Showing 121 - 140 results of 5,484 for search '(( decrease high resistance ) OR ( ((decrease chemotherapy) OR (plus chemotherapy)) resistance ))', query time: 0.58s Refine Results
  1. 121
  2. 122

    Efficacy and safety of adding gemtuzumab ozogamicin to conventional chemotherapy for adult acute myeloid leukemia: a systematic review and meta-analysis by Yuancheng Guo (10834307)

    Published 2021
    “…</p> <p><b>Results:</b> Ten records involving 11 randomized controlled trials (RCTs) met the inclusion criteria. GO plus induction chemotherapy significantly increased RFS (HR: 0.84, 95% CI: 0.73–0.98), decreased the incidence of relapse (OR: 0.78, 95% CI: 0.68–0.91) and resistant disease (OR: 0.72, 95% CI: 0.61–0.84), and had no significant effect on the rate of complete remission (CR) with or without incomplete platelet recovery (OR: 1.21, 95% CI: 0.94–1.55), 30-day mortality (OR: 1.25, 95% CI: 0.99–1.57). …”
  3. 123

    Image_6_Glucose Metabolites Exert Opposing Roles in Tumor Chemoresistance.TIF by Chung-Yen Huang (7902398)

    Published 2019
    “…Our data showed higher glucose transporters in colorectal cancer (CRC) from non-responsive patients than those responsive to chemotherapy. Human CRC cell lines exposed to 5-fluorouracil (5-FU) displayed elevated cell viability and larger tumors in xenograft mouse models if cultured in high-glucose medium. …”
  4. 124

    Data_Sheet_2_Glucose Metabolites Exert Opposing Roles in Tumor Chemoresistance.docx by Chung-Yen Huang (7902398)

    Published 2019
    “…Our data showed higher glucose transporters in colorectal cancer (CRC) from non-responsive patients than those responsive to chemotherapy. Human CRC cell lines exposed to 5-fluorouracil (5-FU) displayed elevated cell viability and larger tumors in xenograft mouse models if cultured in high-glucose medium. …”
  5. 125

    Table_1_Glucose Metabolites Exert Opposing Roles in Tumor Chemoresistance.DOCX by Chung-Yen Huang (7902398)

    Published 2019
    “…Our data showed higher glucose transporters in colorectal cancer (CRC) from non-responsive patients than those responsive to chemotherapy. Human CRC cell lines exposed to 5-fluorouracil (5-FU) displayed elevated cell viability and larger tumors in xenograft mouse models if cultured in high-glucose medium. …”
  6. 126

    Image_2_Glucose Metabolites Exert Opposing Roles in Tumor Chemoresistance.TIF by Chung-Yen Huang (7902398)

    Published 2019
    “…Our data showed higher glucose transporters in colorectal cancer (CRC) from non-responsive patients than those responsive to chemotherapy. Human CRC cell lines exposed to 5-fluorouracil (5-FU) displayed elevated cell viability and larger tumors in xenograft mouse models if cultured in high-glucose medium. …”
  7. 127

    Image_1_Glucose Metabolites Exert Opposing Roles in Tumor Chemoresistance.TIF by Chung-Yen Huang (7902398)

    Published 2019
    “…Our data showed higher glucose transporters in colorectal cancer (CRC) from non-responsive patients than those responsive to chemotherapy. Human CRC cell lines exposed to 5-fluorouracil (5-FU) displayed elevated cell viability and larger tumors in xenograft mouse models if cultured in high-glucose medium. …”
  8. 128

    Image_5_Glucose Metabolites Exert Opposing Roles in Tumor Chemoresistance.TIF by Chung-Yen Huang (7902398)

    Published 2019
    “…Our data showed higher glucose transporters in colorectal cancer (CRC) from non-responsive patients than those responsive to chemotherapy. Human CRC cell lines exposed to 5-fluorouracil (5-FU) displayed elevated cell viability and larger tumors in xenograft mouse models if cultured in high-glucose medium. …”
  9. 129

    Data_Sheet_1_Glucose Metabolites Exert Opposing Roles in Tumor Chemoresistance.PDF by Chung-Yen Huang (7902398)

    Published 2019
    “…Our data showed higher glucose transporters in colorectal cancer (CRC) from non-responsive patients than those responsive to chemotherapy. Human CRC cell lines exposed to 5-fluorouracil (5-FU) displayed elevated cell viability and larger tumors in xenograft mouse models if cultured in high-glucose medium. …”
  10. 130

    Image_4_Glucose Metabolites Exert Opposing Roles in Tumor Chemoresistance.TIF by Chung-Yen Huang (7902398)

    Published 2019
    “…Our data showed higher glucose transporters in colorectal cancer (CRC) from non-responsive patients than those responsive to chemotherapy. Human CRC cell lines exposed to 5-fluorouracil (5-FU) displayed elevated cell viability and larger tumors in xenograft mouse models if cultured in high-glucose medium. …”
  11. 131

    Image_3_Glucose Metabolites Exert Opposing Roles in Tumor Chemoresistance.TIF by Chung-Yen Huang (7902398)

    Published 2019
    “…Our data showed higher glucose transporters in colorectal cancer (CRC) from non-responsive patients than those responsive to chemotherapy. Human CRC cell lines exposed to 5-fluorouracil (5-FU) displayed elevated cell viability and larger tumors in xenograft mouse models if cultured in high-glucose medium. …”
  12. 132
  13. 133
  14. 134
  15. 135
  16. 136

    Image_3_Glutamine Metabolism Drives Growth in Advanced Hormone Receptor Positive Breast Cancer.TIF by Diane M. Demas (7121717)

    Published 2019
    “…Among patients treated with endocrine therapy, high GLS expression was associated with decreased disease free survival (DFS) from a multivariable model with GLS expression treated as dichotomous. …”
  17. 137

    Image_5_Glutamine Metabolism Drives Growth in Advanced Hormone Receptor Positive Breast Cancer.TIF by Diane M. Demas (7121717)

    Published 2019
    “…Among patients treated with endocrine therapy, high GLS expression was associated with decreased disease free survival (DFS) from a multivariable model with GLS expression treated as dichotomous. …”
  18. 138

    Image_1_Glutamine Metabolism Drives Growth in Advanced Hormone Receptor Positive Breast Cancer.TIF by Diane M. Demas (7121717)

    Published 2019
    “…Among patients treated with endocrine therapy, high GLS expression was associated with decreased disease free survival (DFS) from a multivariable model with GLS expression treated as dichotomous. …”
  19. 139

    Image_4_Glutamine Metabolism Drives Growth in Advanced Hormone Receptor Positive Breast Cancer.TIF by Diane M. Demas (7121717)

    Published 2019
    “…Among patients treated with endocrine therapy, high GLS expression was associated with decreased disease free survival (DFS) from a multivariable model with GLS expression treated as dichotomous. …”
  20. 140

    Image_2_Glutamine Metabolism Drives Growth in Advanced Hormone Receptor Positive Breast Cancer.TIF by Diane M. Demas (7121717)

    Published 2019
    “…Among patients treated with endocrine therapy, high GLS expression was associated with decreased disease free survival (DFS) from a multivariable model with GLS expression treated as dichotomous. …”